RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

  • ReconRecon

    Recon: Lundbeck Buys Alder for $2B; Purdue Pharma Files for Bankruptcy

    Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.   In Focus: US First peanut allergy treatment gains backing from FDA advisory panel ( Science ) ( Atlantic ) ( AP ) Purdue Pharma, maker of OxyContin and other drugs, files for bankruptcy ( Stat ) ( Bloomberg ) ( WSJ ) ( Guardian ) Opioid Defendants Seek to Disqualify Judge Overseeing 2,300 Cases ( NY Times ) The Startup That Manipulated Data to Get a Miracle Drug to Market ...
  • European Trade Regulators Charge Companies for 'Pay-for-Delay' Agreements

    • 26 July 2012
    If industry practitioners of so-called pay-for-delay settlements are worried about the climate for the legal agreements in the US after a recent court ruling against the measures, they should be just as concerned about European regulators, reports Reuters and The Financial Times . The agreements are commonly used by pharmaceutical manufacturers of branded products to delay the entry of generic competition in return for large cash payments or other forms of compensat...